CSI, Imaging & Innovation 2017

on .

Friday June 30, 2017
Frankfurt, Germany
Main Room of the Congress Center

CSI, Imaging & Innovation 2017
Parallel Sessions
Seminar: Challenges with TAVI
Moderator: David Hildick-Smith, MD / Nalan Schnelle, MD

Agenda: 10:30-12:40

New standards for assessing neurologic damage in CV clinical trials - Andreas Baumbach, MD
Can we calculate the cost benefit ratio of embolic protection? - Andreas Baumbach, MD
Claret - tbd
Triguard (Keystone)
Azeem Latbib, MD
Emboline - tbd
Bicuspid and heavily calcified aortic valves: Experience with the Venus valve - tbd
Should we worry about transcatheter heart valve durability? - Danny Dvir
Valve in valve implantations: important lessons from bench to bedside - Danny Dvir
The valve has embolized - now what? - tbd
More than mild regulation after TAVI: assessment and management - Antonio Colombo, MD
Management of iliac rupture - Stefan Toggweiler
The TriGuard Cerebral Protection Device is not commercially available in the USA.